Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps.
Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps.
复制标题
使用密集的插图地图发现与与心脏代谢风险相关的遗传基因座的发现和完善。
DOI:
10.1038/ng.3668
复制
发表时间:
2016-11
期刊:
影响因子:
30.8
通讯作者:
Soranzo N
中科院分区:
文献类型:
--
作者:
Iotchkova V;Huang J;Morris JA;Jain D;Barbieri C;Walter K;Min JL;Chen L;Astle W;Cocca M;Deelen P;Elding H;Farmaki AE;Franklin CS;Franberg M;Gaunt TR;Hofman A;Jiang T;Kleber ME;Lachance G;Luan J;Malerba G;Matchan A;Mead D;Memari Y;Ntalla I;Panoutsopoulou K;Pazoki R;Perry JRB;Rivadeneira F;Sabater-Lleal M;Sennblad B;Shin SY;Southam L;Traglia M;van Dijk F;van Leeuwen EM;Zaza G;Zhang W;UK10K Consortium;Amin N;Butterworth A;Chambers JC;Dedoussis G;Dehghan A;Franco OH;Franke L;Frontini M;Gambaro G;Gasparini P;Hamsten A;Issacs A;Kooner JS;Kooperberg C;Langenberg C;Marz W;Scott RA;Swertz MA;Toniolo D;Uitterlinden AG;van Duijn CM;Watkins H;Zeggini E;Maurano MT;Timpson NJ;Reiner AP;Auer PL;Soranzo N
Large-scale whole genome sequence datasets offer novel opportunities to identify genetic variation underlying human traits. Here we apply genotype imputation based on whole genome sequence data from the UK10K and the 1000 Genomes Projects into 35,981 study participants of European ancestry, followed by association analysis with twenty quantitative cardiometabolic and hematologic traits. We describe 17 novel associations, including six rare (minor allele frequency [MAF]<1%) or low frequency variants (1%<MAF<5%) with platelet count (PLT), red cell indices (MCH, MCV) and high-density lipoprotein (HDL) cholesterol. Applying fine-mapping analysis to 233 known and novel loci associated with the twenty traits, we resolve associations of 59 loci to credible sets of 20 or less variants, and describe trait enrichments within regions of predicted regulatory function. These findings augment understanding of the allelic architecture of risk factors for cardiometabolic and hematologic diseases, and provide additional functional insights with the identification of potentially novel biological targets.